Antitrust scrutiny of healthcare markets is nothing new. The Biden Administration and first Trump Administration focused antitrust enforcement efforts across the healthcare and life sciences industries. The newly installed Trump Administration is poised to continue its focus on antitrust enforcement in healthcare markets. Beyond federal enforcers, state AGs are also likely to remain active in the healthcare space, particularly in “blue” states that might perceive federal antitrust enfo
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 18.97.9.170
Please verify email or join us to access premium content!